Translational research: A patient-centered approach to bridge the valley of death

Animal models have evolved to be a key component of translational research of cancer, and they are now extensively used to test drug candidates, predict drug responses, and essentially drive discovery of cancer biology. However, the model-centric approach has not yielded the expected abundance of tr...

Full description

Saved in:
Bibliographic Details
Published inCancer Cell Vol. 40; no. 6; pp. 565 - 568
Main Authors Thomas, Anish, Desai, Parth, Takahashi, Nobuyuki
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 13.06.2022
Elsevier BV
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Animal models have evolved to be a key component of translational research of cancer, and they are now extensively used to test drug candidates, predict drug responses, and essentially drive discovery of cancer biology. However, the model-centric approach has not yielded the expected abundance of treatment advances. We propose that the focus of translational research needs to shift from animal models to human patients, and the goal should be to understand why tumor responses and outcomes are so variable between patients and how it can be predicted at the individual level and thus to generate hypotheses that are more relevant to people than to atypically sensitive animal models.
AbstractList Animal models have evolved to be a key component of translational research of cancer, and they are now extensively used to test drug candidates, predict drug responses, and essentially drive discovery of cancer biology. However, the model-centric approach has not yielded the expected abundance of treatment advances. We propose that the focus of translational research needs to shift from animal models to human patients, and the goal should be to understand why tumor responses and outcomes are so variable between patients and how it can be predicted at the individual level and thus to generate hypotheses that are more relevant to people than to atypically sensitive animal models.Animal models have evolved to be a key component of translational research of cancer, and they are now extensively used to test drug candidates, predict drug responses, and essentially drive discovery of cancer biology. However, the model-centric approach has not yielded the expected abundance of treatment advances. We propose that the focus of translational research needs to shift from animal models to human patients, and the goal should be to understand why tumor responses and outcomes are so variable between patients and how it can be predicted at the individual level and thus to generate hypotheses that are more relevant to people than to atypically sensitive animal models.
Animal models have evolved to be a key component of translational research of cancer, and they are now extensively used to test drug candidates, predict drug responses, and essentially drive discovery of cancer biology. However, the model-centric approach has not yielded the expected abundance of treatment advances. We propose that the focus of translational research needs to shift from animal models to human patients, and the goal should be to understand why tumor responses and outcomes are so variable between patients and how it can be predicted at the individual level and thus to generate hypotheses that are more relevant to people than to atypically sensitive animal models.
Author Desai, Parth
Thomas, Anish
Takahashi, Nobuyuki
Author_xml – sequence: 1
  givenname: Anish
  surname: Thomas
  fullname: Thomas, Anish
  email: anish.thomas@nih.gov
  organization: Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
– sequence: 2
  givenname: Parth
  surname: Desai
  fullname: Desai, Parth
  organization: Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
– sequence: 3
  givenname: Nobuyuki
  surname: Takahashi
  fullname: Takahashi, Nobuyuki
  organization: Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
BackLink https://cir.nii.ac.jp/crid/1871709543071821568$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/35561672$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1r3DAQhkVJaD7aX1AoOvTQix2NrS8XegghSQuBUkjPYiyPu1q89lbSBvLvq80mlxxyGQnxvDPimTN2NC8zMfYJRA0C9MW69p6mqW5E09RC1gLkO3YK1tiq1VYflbtqVaVB2BN2ltJalBSY7j07aZXSoE1zyn7fR5zThDksM048UiKMfvWNX_JteaQ5V74UijRw3G7jgn7F88L7GIa_xPOK-ANOEz3yZeQDYV59YMcjTok-Pp_n7M_N9f3Vj-ru1-3Pq8u7ykslcwU02KFXckTdmxFbBAV9K0mSsbbXkhqtdEdgZSegt0pZJQlxBDSmV0K35-zroW_51L8dpew2Ie2F4EzLLrlGa2m6ruQL-vkZ3fUbGtw2hg3GR_eioQDdAfBxSSnS6HzIT05yxDA5EG6v3K3dk3K3V-6EdEV5ybavsi_t3059OaTmEMqwfS2bAyM6JVthwDagtC3Y9wNGxeRDoOiSL0vxNIRIPrthCW-O-Q-if6Su
CitedBy_id crossref_primary_10_1097_CCO_0000000000000895
crossref_primary_10_2196_50463
crossref_primary_10_3390_cancers14174209
crossref_primary_10_1186_s13073_025_01438_4
crossref_primary_10_1016_j_cell_2023_12_004
crossref_primary_10_1016_j_xcrm_2024_101610
crossref_primary_10_1016_j_pccm_2024_11_003
crossref_primary_10_1158_2159_8290_CD_22_0796
Cites_doi 10.1073/pnas.1222878110
10.1016/j.ccell.2020.10.015
10.1158/1078-0432.CCR-19-3841
10.1016/j.cell.2021.11.017
10.1056/NEJMoa1916623
10.1038/ng.3967
10.1038/453840a
10.1038/sj.embor.7400422
10.1038/s41568-018-0095-3
10.1001/jama.2017.3438
10.1038/nature10937
10.1158/1078-0432.CCR-21-2275
10.1038/s41467-022-29517-9
10.1056/NEJMoa040938
ContentType Journal Article
Copyright 2022
Published by Elsevier Inc.
Copyright_xml – notice: 2022
– notice: Published by Elsevier Inc.
DBID RYH
AAYXX
CITATION
NPM
7X8
DOI 10.1016/j.ccell.2022.04.014
DatabaseName CiNii Complete
CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1878-3686
EndPage 568
ExternalDocumentID 35561672
10_1016_j_ccell_2022_04_014
S1535610822001763
Genre Journal Article
GroupedDBID ---
--K
0R~
1~5
29B
2WC
4.4
457
4G.
53G
5GY
62-
6J9
7-5
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAKRW
AAKUH
AALRI
AAUCE
AAVLU
AAXUO
ABJNI
ABMAC
ABMWF
ABVKL
ACGFO
ACGFS
ADBBV
ADEZE
ADJPV
AEFWE
AENEX
AEXQZ
AFTJW
AGKMS
AITUG
ALKID
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BAWUL
CS3
DIK
DU5
E3Z
EBS
F5P
FCP
FDB
FEDTE
FIRID
HVGLF
IH2
IHE
IXB
J1W
JIG
M3Z
M41
O-L
O9-
OK1
P2P
RCE
ROL
RPZ
SES
SSZ
TR2
UDS
WQ6
ZA5
AAFWJ
AAMRU
AAYWO
ABDGV
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AGCQF
AIGII
AKAPO
AKBMS
AKRWK
AKYEP
APXCP
RYH
5VS
AAIKJ
AAQFI
AAYXX
AGHFR
CITATION
EJD
HZ~
OZT
RIG
UHS
EFKBS
NPM
7X8
ID FETCH-LOGICAL-c454t-1ed8db54fa6b7fa3a151b34e4e788b64e26569e184901b855854eaaf1a77b5063
IEDL.DBID IXB
ISSN 1535-6108
1878-3686
IngestDate Fri Jul 11 03:57:21 EDT 2025
Mon Jul 21 05:46:28 EDT 2025
Tue Jul 01 01:26:26 EDT 2025
Thu Apr 24 23:09:11 EDT 2025
Fri Jun 27 00:25:27 EDT 2025
Fri Feb 23 02:40:58 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Published by Elsevier Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c454t-1ed8db54fa6b7fa3a151b34e4e788b64e26569e184901b855854eaaf1a77b5063
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-8592-6528
0000-0002-7715-4919
PMID 35561672
PQID 2664799849
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_2664799849
pubmed_primary_35561672
crossref_citationtrail_10_1016_j_ccell_2022_04_014
crossref_primary_10_1016_j_ccell_2022_04_014
nii_cinii_1871709543071821568
elsevier_sciencedirect_doi_10_1016_j_ccell_2022_04_014
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-06-13
PublicationDateYYYYMMDD 2022-06-13
PublicationDate_xml – month: 06
  year: 2022
  text: 2022-06-13
  day: 13
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cancer Cell
PublicationTitleAlternate Cancer Cell
PublicationYear 2022
Publisher Elsevier Inc
Elsevier BV
Publisher_xml – name: Elsevier Inc
– name: Elsevier BV
References Howlader, Forjaz, Mooradian, Meza, Kong, Cronin, Mariotto, Lowy, Feuer (bib6) 2020; 383
Jänne, van den Heuvel, Barlesi, Cobo, Mazieres, Crinò, Orlov, Blackhall, Wolf, Garrido (bib7) 2017; 317
Raghavan, Winter, Navia, Williams, DenAdel, Lowder, Galvez-Reyes, Kalekar, Mulugeta, Kapner (bib11) 2021; 184
Chen, Cheng, Walton, Wang, Ebi, Shimamura, Liu, Tupper, Ouyang, Li (bib4) 2012; 483
Demetrius (bib5) 2005; 6
Seok, Warren, Cuenca, Mindrinos, Baker, Xu, Richards, McDonald-Smith, Gao, Hennessy (bib12) 2013; 110
Ben-David, Beroukhim, Golub (bib1) 2019; 19
Lynch, Bell, Sordella, Gurubhagavatula, Okimoto, Brannigan, Harris, Haserlat, Supko, Haluska (bib9) 2004; 350
Stein, Ferrarone, Gardner, Chang, Wu, Chen, Hollstein, Yuan, Liang, Coukos (bib13) 2021
Palmer, Izar, Hwangbo, Sorger (bib10) 2022; 28
Takahashi, Surolia, Thomas (bib14) 2020; 26
Butler (bib3) 2008; 453
Ben-David, Ha, Tseng, Greenwald, Oh, Shih, McFarland, Wong, Boehm, Beroukhim, Golub (bib2) 2017; 49
Lissa, Takahashi, Desai, Manukyan, Schultz, Rajapakse, Velez, Mulford, Roper, Nichols (bib8) 2022; 19
Wheeler, Takebe, Hinoue, Hoadley, Cardenas, Hamilton, Laird, Wang, Johnson, Dewal (bib15) 2021; 39
Jänne (10.1016/j.ccell.2022.04.014_bib7) 2017; 317
Ben-David (10.1016/j.ccell.2022.04.014_bib1) 2019; 19
Chen (10.1016/j.ccell.2022.04.014_bib4) 2012; 483
Stein (10.1016/j.ccell.2022.04.014_bib13) 2021
Raghavan (10.1016/j.ccell.2022.04.014_bib11) 2021; 184
Palmer (10.1016/j.ccell.2022.04.014_bib10) 2022; 28
Wheeler (10.1016/j.ccell.2022.04.014_bib15) 2021; 39
Ben-David (10.1016/j.ccell.2022.04.014_bib2) 2017; 49
Butler (10.1016/j.ccell.2022.04.014_bib3) 2008; 453
Howlader (10.1016/j.ccell.2022.04.014_bib6) 2020; 383
Lissa (10.1016/j.ccell.2022.04.014_bib8) 2022; 19
Takahashi (10.1016/j.ccell.2022.04.014_bib14) 2020; 26
Seok (10.1016/j.ccell.2022.04.014_bib12) 2013; 110
Demetrius (10.1016/j.ccell.2022.04.014_bib5) 2005; 6
Lynch (10.1016/j.ccell.2022.04.014_bib9) 2004; 350
References_xml – volume: 26
  start-page: 2452
  year: 2020
  end-page: 2456
  ident: bib14
  article-title: Targeting DNA repair to drive immune responses: it's time to reconsider the strategy for clinical translation
  publication-title: Clin. Cancer Res.
– volume: 19
  start-page: 97
  year: 2019
  end-page: 109
  ident: bib1
  article-title: Genomic evolution of cancer models: perils and opportunities
  publication-title: Nat. Rev. Cancer
– volume: 39
  start-page: 38
  year: 2021
  end-page: 53.e37
  ident: bib15
  article-title: Molecular features of cancers exhibiting exceptional responses to treatment
  publication-title: Cancer Cell
– volume: 483
  start-page: 613
  year: 2012
  end-page: 617
  ident: bib4
  article-title: A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
  publication-title: Nature
– volume: 49
  start-page: 1567
  year: 2017
  end-page: 1575
  ident: bib2
  article-title: Patient-derived xenografts undergo mouse-specific tumor evolution
  publication-title: Nat. Genet.
– volume: 383
  start-page: 640
  year: 2020
  end-page: 649
  ident: bib6
  article-title: The effect of advances in lung-cancer treatment on population mortality
  publication-title: N. Engl. J. Med.
– volume: 184
  start-page: 6119
  year: 2021
  end-page: 6137.e6126
  ident: bib11
  article-title: Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
  publication-title: Cell
– volume: 19
  start-page: 2023
  year: 2022
  ident: bib8
  article-title: Integrated genomic and transcriptomic analysis of small cell lung cancer reveals inter-and intratumoral heterogeneity and a novel chemotherapy-refractory subtype
  publication-title: Nat. Commun.
– year: 2021
  ident: bib13
  article-title: Non-conserved metabolic regulation by LKB1 distinguishes human and mouse lung adenocarcinoma
  publication-title: bioRxiv
– volume: 6
  start-page: S39
  year: 2005
  end-page: S44
  ident: bib5
  article-title: Of mice and men. When it comes to studying ageing and the means to slow it down, mice are not just small humans
  publication-title: EMBO Rep.
– volume: 350
  start-page: 2129
  year: 2004
  end-page: 2139
  ident: bib9
  article-title: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
  publication-title: N. Engl. J. Med.
– volume: 317
  start-page: 1844
  year: 2017
  end-page: 1853
  ident: bib7
  article-title: Selumetinib plus docetaxel compared with docetaxel alone and progression-free survival in patients with KRAS-mutant advanced non-small cell lung cancer: the SELECT-1 randomized clinical trial
  publication-title: JAMA
– volume: 28
  start-page: 368
  year: 2022
  end-page: 377
  ident: bib10
  article-title: Predictable clinical benefits without evidence of synergy in trials of combination therapies with immune-checkpoint inhibitors
  publication-title: Clin. Cancer Res.
– volume: 453
  start-page: 840
  year: 2008
  end-page: 842
  ident: bib3
  article-title: Translational research: crossing the valley of death
  publication-title: Nature
– volume: 110
  start-page: 3507
  year: 2013
  end-page: 3512
  ident: bib12
  article-title: Genomic responses in mouse models poorly mimic human inflammatory diseases
  publication-title: Proc. Natl. Acad. Sci. U S A
– volume: 110
  start-page: 3507
  year: 2013
  ident: 10.1016/j.ccell.2022.04.014_bib12
  article-title: Genomic responses in mouse models poorly mimic human inflammatory diseases
  publication-title: Proc. Natl. Acad. Sci. U S A
  doi: 10.1073/pnas.1222878110
– volume: 39
  start-page: 38
  year: 2021
  ident: 10.1016/j.ccell.2022.04.014_bib15
  article-title: Molecular features of cancers exhibiting exceptional responses to treatment
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2020.10.015
– year: 2021
  ident: 10.1016/j.ccell.2022.04.014_bib13
  article-title: Non-conserved metabolic regulation by LKB1 distinguishes human and mouse lung adenocarcinoma
  publication-title: bioRxiv
– volume: 26
  start-page: 2452
  year: 2020
  ident: 10.1016/j.ccell.2022.04.014_bib14
  article-title: Targeting DNA repair to drive immune responses: it's time to reconsider the strategy for clinical translation
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-19-3841
– volume: 184
  start-page: 6119
  year: 2021
  ident: 10.1016/j.ccell.2022.04.014_bib11
  article-title: Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
  publication-title: Cell
  doi: 10.1016/j.cell.2021.11.017
– volume: 383
  start-page: 640
  year: 2020
  ident: 10.1016/j.ccell.2022.04.014_bib6
  article-title: The effect of advances in lung-cancer treatment on population mortality
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1916623
– volume: 49
  start-page: 1567
  year: 2017
  ident: 10.1016/j.ccell.2022.04.014_bib2
  article-title: Patient-derived xenografts undergo mouse-specific tumor evolution
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3967
– volume: 453
  start-page: 840
  year: 2008
  ident: 10.1016/j.ccell.2022.04.014_bib3
  article-title: Translational research: crossing the valley of death
  publication-title: Nature
  doi: 10.1038/453840a
– volume: 6
  start-page: S39
  year: 2005
  ident: 10.1016/j.ccell.2022.04.014_bib5
  article-title: Of mice and men. When it comes to studying ageing and the means to slow it down, mice are not just small humans
  publication-title: EMBO Rep.
  doi: 10.1038/sj.embor.7400422
– volume: 19
  start-page: 97
  year: 2019
  ident: 10.1016/j.ccell.2022.04.014_bib1
  article-title: Genomic evolution of cancer models: perils and opportunities
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-018-0095-3
– volume: 317
  start-page: 1844
  year: 2017
  ident: 10.1016/j.ccell.2022.04.014_bib7
  article-title: Selumetinib plus docetaxel compared with docetaxel alone and progression-free survival in patients with KRAS-mutant advanced non-small cell lung cancer: the SELECT-1 randomized clinical trial
  publication-title: JAMA
  doi: 10.1001/jama.2017.3438
– volume: 483
  start-page: 613
  year: 2012
  ident: 10.1016/j.ccell.2022.04.014_bib4
  article-title: A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
  publication-title: Nature
  doi: 10.1038/nature10937
– volume: 28
  start-page: 368
  year: 2022
  ident: 10.1016/j.ccell.2022.04.014_bib10
  article-title: Predictable clinical benefits without evidence of synergy in trials of combination therapies with immune-checkpoint inhibitors
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-21-2275
– volume: 19
  start-page: 2023
  year: 2022
  ident: 10.1016/j.ccell.2022.04.014_bib8
  article-title: Integrated genomic and transcriptomic analysis of small cell lung cancer reveals inter-and intratumoral heterogeneity and a novel chemotherapy-refractory subtype
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-022-29517-9
– volume: 350
  start-page: 2129
  year: 2004
  ident: 10.1016/j.ccell.2022.04.014_bib9
  article-title: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa040938
SSID ssj0016179
ssib058492473
Score 2.44655
Snippet Animal models have evolved to be a key component of translational research of cancer, and they are now extensively used to test drug candidates, predict drug...
SourceID proquest
pubmed
crossref
nii
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 565
SubjectTerms Animals
Humans
Patient-Centered Care
Translational Research, Biomedical
Title Translational research: A patient-centered approach to bridge the valley of death
URI https://dx.doi.org/10.1016/j.ccell.2022.04.014
https://cir.nii.ac.jp/crid/1871709543071821568
https://www.ncbi.nlm.nih.gov/pubmed/35561672
https://www.proquest.com/docview/2664799849
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fS8MwEA5zD-KL-NuqGxF8tGxtr23m2xyOqUwQHewtJG2Kk9EO3QT_e-_adODDfPCl0JKUcJfcfZdcvmPsKkYvo4VJ3F7igQva11TmJXJToXyTBEJHmvYhx0_RaAIP03DaYIP6LgylVVrbX9n00lrbLx0rzc5iNuu84Fol548ejkxtRIyfAYjyEt_0dn2SgB66V3Gmhi61rpmHyhyvhHbHMUj0_ZLv1INN3mkrn802Y9DSFw332K4FkbxfjXOfNUx-wLbH9pj8kD2XHmhu9_m4JfR5u-F9bnlUXUrKpDKdvCYV58uCV7e3OGJC_kU1Vr55kfGUQOIRmwzvXgcj19ZOcBMIYel6JhWpDiFTkY4zFSj07DoAAwZjXh2B8RHI9QzGdwgItAgxagCjVOapONYh4pZj1syL3JwyjhBLezpGnJhlkIpQZaqLf_RUIJIgyYzD_FpmMrHE4lTfYi7rDLJ3WQpakqBlFyQK2mHX606Lilfj7-ZRrQz5a3pItPx_d2yh6nBc9PQwOowRUwIaNoyrMHQVDruslSpxYVF3lZti9SkRuUCMwSj0HHZSaXs90oCKikaxf_bfYZ2zHXqjnDMvuGDN5cfKtBDdLHUbcf39Y7ucxD-kMPR5
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1NT9wwEB3xIbVcKugHbAvUldpboyWOE2cr9UBL0W5hkaqCtDfXThyxCGVRWVrxu_oH-yZxVuoBDpW45JDEljVjz3tjj2eI3mqgjMt9EQ2KWEXKScdlXrKozK30RZK7zPE-5PgkG56pr5N0skR_urswHFYZbH9r0xtrHd70gzT7V9Np_zvWKoM_EI5NbdZVsD7yt7_ht11_HB1Aye-kPPxy-nkYhdICUaFSNY9iX-alS1VlM6crm1gAn0uUVx4uocuUl-A5Aw_3B3jp8hSkWnlrq9hq7VLAOvpdplWwD83WYDT5tDi6ACUYtEla04iH16U6aoLKCt6Oh1cqZZNgNVZ3weFyPZ3eTXob8DtcpyeBtYr9VjAbtOTrp_RoHM7ln9G3BvIuw8aiCBmEzj-IfRESt0YcBcp1QUWXxVzMZ6K9LiZAQsUvLupyK2aVKJmVPqezB5HoC1qpZ7XfIgGputhpENOqUmWe2sruocfYJnmRFJXvkexkZoqQyZwLalyaLmTtwjSCNixos6cMBN2j94tGV20ij_t_zzplmH_mowHU3N9wB6rDuPgZwx3VILEKlhSOHHzlvEdvOqUarGRubms_u7k2oEpKw_tVgx5tttpejDThKqaZli__d1iv6fHwdHxsjkcnR69ojb9wwFucbNPK_OeN3wG1mrvdZioL-vHQa-cv6IkwPQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Translational+research%3A+A+patient-centered+approach+to+bridge+the+valley+of+death&rft.jtitle=Cancer+cell&rft.au=Thomas%2C+Anish&rft.au=Desai%2C+Parth&rft.au=Takahashi%2C+Nobuyuki&rft.date=2022-06-13&rft.issn=1878-3686&rft.eissn=1878-3686&rft.volume=40&rft.issue=6&rft.spage=565&rft_id=info:doi/10.1016%2Fj.ccell.2022.04.014&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1535-6108&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1535-6108&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1535-6108&client=summon